Table 1.
The Characteristics of HIV+ -Smoking Quitters receiving care at the UAB 1917 HIV/AIDS clinic between April 2008–April 2017 according to Relapse status
| Overall N(473) a N(%) |
Relapse (Yes = 240) a n(%) |
Relapse (No = 233) a n(%) |
|
|---|---|---|---|
| Socio-demographic | |||
| Age (years), mean (SD) | 46.7 (11.2) | 46.4 (11.1) | 47.1 (11.4) |
| Gender/sexual orientation | |||
| Women | 75 (16.2) | 38 (16.1) | 37 (16.3) |
| Male heterosexual | 79 (17.1) | 35 (14.8) | 44 (19.4) |
| MSM | 309 (66.7) | 163 (69.1) | 146 (64.3) |
| Race/ethnicity | |||
| White | 231 (49.3) | 120 (50.2) | 111 (48.3) |
| African American | 238 (50.7) | 119 (49.8) | 119 (51.7) |
| Clinical/medical | |||
| Length in care (years) mean (SD) | 8.8 (4.74) | 9.14 (4.62) | 8.54 (4.85) |
| Adherent to ART | 66 (15.6) | 34 (16.4) | 32 (14.7) |
| Health Insurance | |||
| Private | 152 (32.1) | 78 (36.2) | 74 (31.8) |
| Public | 126 (26.6) | 64 (26.7) | 62 (26.6) |
| Uninsured | 195 (41.2) | 98 (40.8) | 97 (41.6) |
| Comorbiditiesb | |||
| Cardiovascular | 70 (14.8) | 30 (12.5) | 40 (17.2) |
| Respiratory | 101 (21.4) | 59 (24.6) | 42 (18.0) |
| Metabolic | 71 (15.0) | 32 (13.3) | 39(16.7) |
| Cancer | 34 (7.2) | 21 (8.80) | 13 (5.60) |
| Laboratory parameterc | |||
| Plasma HIV-1 RNA < 200 copies/ml | 386 (81.6) | 190 (79.2) | 196 (84.1) |
| CD4 count (cells/μL) | |||
| < 200 | 49 (10.4) | 20 (8.40) | 29 (12.4) |
| ≥ 200 | 423 (89.6) | 219 (91.6) | 204 (87.6) |
| Behavioral and psychologicale | |||
| Depressive symptoms | 97 (20.9) | 58 (24.6) | 39 (17.0) |
| Anxiety symptoms | 130 (28.2) | 80 (34.2) | 50 (22.0) |
| Substance abused | |||
| Never | 65 (13.7) | 33 (13.7) | 32 (13.7) |
| Prior | 177 (37.4) | 91 (37.9) | 86 (36.9) |
| Current | 49 (10.4) | 28 (11.7) | 21 (9.01) |
| Unknown | 182 (38.5) | 88 (36.7) | 94 (40.3) |
| Alcohol abuse | |||
| No risk | 150 (34.6) | 74 (33.6) | 136 (65.1) |
| Low risk | 232 (53.6) | 111 (50.5) | 121 (56.8) |
| At risk | 51 (11.8) | 35 (15.9) | 16 (7.5) |
Abbreviations: ART antiretroviral therapy, HIV human immunodeficiency virus, MSM men who have sex with men, SD standard deviation, UAB University of Alabama at Birmingham Missing data: Race, 0.8%; Gender/sexual orientation, 2.1%; Adherence, 10.4%; CD4 count, 0.2%; Depression (PHQ-9), 1.7%; Anxiety (PHQ-A), 2.5%; Alcohol abuse, 8.5%;
aColumn percentages; bComorbidities: respiratory (asthma, chronic obstructive pulmonary disease, bacterial pneumonia); metabolic (diabetes and dyslipidemia); cardiovascular (stroke, myocardial infarction, coronary artery disease, hypertension); cLab value closest to index visit; dSubstance abuse includes street opioids, prescription opioids, marijuana, crack/cocaine, amphetamines, sedatives, inhalants, hallucinogens; eAt baseline quit value
Plasma HIV-1 RNA < 200 copies/ml, Depressive symptoms, Anxiety symptoms, Alcohol abuse were significant at p value < 0.05 level